Dr. Kim on SS22 316 Edoxaban dosing

John S. Kim, M.D., a member of the American Heart Association’s Council on Lifelong Congenital Heart Disease and Heart Health in the Young and director of the Cardiac Thrombosis Management Program at the Heart Institute of the Children’s Hospital Colorado in Aurora, offers perspective on the news release - Anti-clotting pill may spare kids from frequent injections, blood tests, dietary changes - American Heart Association Scientific Sessions 2022, Abstract 316.

Transcript (txt)

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (61.8 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED